Nathan Zelyas

2.1k total citations
48 papers, 952 citations indexed

About

Nathan Zelyas is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Nathan Zelyas has authored 48 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 25 papers in Epidemiology and 6 papers in Modeling and Simulation. Recurrent topics in Nathan Zelyas's work include SARS-CoV-2 and COVID-19 Research (19 papers), Respiratory viral infections research (16 papers) and SARS-CoV-2 detection and testing (16 papers). Nathan Zelyas is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), Respiratory viral infections research (16 papers) and SARS-CoV-2 detection and testing (16 papers). Nathan Zelyas collaborates with scholars based in Canada, Hong Kong and United States. Nathan Zelyas's co-authors include Byron M. Berenger, Graham Tipples, Jamil N. Kanji, Linda Chui, Kanti Pabbaraju, Clayton MacDonald, Jia Hu, Mathew Diggle, Brendon Parsons and Nelson Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Nathan Zelyas

45 papers receiving 928 citations

Peers

Countries citing papers authored by Nathan Zelyas

Since Specialization

Citations

This map shows the geographic impact of Nathan Zelyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Zelyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Zelyas more than expected).

Fields of papers citing papers by Nathan Zelyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Zelyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Zelyas. The network helps show where Nathan Zelyas may publish in the future.

Co-authorship network of co-authors of Nathan Zelyas

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Zelyas. A scholar is included among the top collaborators of Nathan Zelyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Zelyas. Nathan Zelyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026 2026 ·Eurosurveillance ·(unknown), Suzana Sabaiduc, (unknown), (unknown), Romy Olsha, (unknown), (unknown), (unknown), (unknown), Isabelle Meunier, (unknown), (unknown), Nathan Zelyas, Agatha N. Jassem, (unknown), Charlene Ranadheera, Ruimin Gao, (unknown), (unknown)	0
2	Early warning COVID-19 outbreak in long-term care facilities using wastewater surveillance: correlation, prediction, and interaction with clinical and serological statuses 2024 ·The Lancet Microbe ·Xiaoli Pang, Bonita E. Lee, Tiejun Gao, Rhonda J. Rosychuk, (unknown), (unknown), (unknown), Nathan Zelyas, (unknown), (unknown), (unknown), (unknown), John Kim, Heidi Wood, Alyssia Robinson, Michael D. Parkins, Casey R. J. Hubert, Kevin J. Frankowski, Steve E. Hrudey, (unknown)	2
3	Early influenza vaccine effectiveness estimates using routinely collected data, Alberta, Canada, 2023/24 season 2024 ·Eurosurveillance ·(unknown), Carla Ickert, Nathan Zelyas, Jeffrey C. Kwong, Sarah A. Buchan	18
4	Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing 2023 ·Scientific Reports ·Nathan Zelyas, Kanti Pabbaraju, Matthew A. Croxen, Tarah Lynch, Emily McCullough, (unknown), Sandy Shokoples, Anita Wong, Jamil N. Kanji, Graham Tipples	0
5	Hepatitis B virus reactivation in hepatitis B core antibody positive lung transplant recipients 2023 ·SHILAP Revista de lepidopterología ·(unknown), Nathan Zelyas, Vanessa Meier‐Stephenson, K. Halloran, Karen Doucette	3
6	Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern 2022 ·Journal of Virological Methods ·Kanti Pabbaraju, Nathan Zelyas, Anita Wong, Matthew A. Croxen, Tarah Lynch, Emily Buss, (unknown), Sandy Shokoples, Jamil N. Kanji, Graham Tipples	9
7	Effect of not vortexing nasopharyngeal and throat swabs on SARS-CoV-2 nucleic acid detection: A pilot study 2022 ·Journal of Virological Methods ·Jamil N. Kanji, Kanti Pabbaraju, Anita Wong, (unknown), (unknown), (unknown), (unknown), Graham Tipples, Nathan Zelyas	2
8	A pragmatic randomized controlled trial of rapid on-site influenza and respiratory syncytial virus PCR testing in paediatric and adult populations 2022 ·BMC Infectious Diseases ·(unknown), Lawrence de Koning, Isolde Seiden‐Long, Nathan Zelyas, Deirdre L. Church, Byron M. Berenger	10
9	Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2 2021 ·Journal of Virological Methods ·Kanti Pabbaraju, Anita Wong, (unknown), Nathan Zelyas, Graham Tipples	21
10	Evaluation of 5 commercial assays for the detection of Mycoplasma genitalium and other Urogenital Mycoplasmas 2021 ·Medical Microbiology and Immunology ·Prenilla Naidu, Sandy Shokoples, Irene Martín, Nathan Zelyas, Ameeta E. Singh	6
11	Respiratory virus coinfections with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) continue to be rare one year into the coronavirus disease 2019 (COVID-19) pandemic in Alberta, Canada (June 2020–May 2021) 2021 ·Infection Control and Hospital Epidemiology ·Jamil N. Kanji, Nathan Zelyas, Kanti Pabbaraju, (unknown), Anita Wong, (unknown), Emily Buss, (unknown), Byron M. Berenger, Mathew Diggle, Natalie C. Marshall, John Conly, Graham Tipples	6
12	Clinical evaluation of nasopharyngeal, midturbinate nasal and oropharyngeal swabs for the detection of SARS-CoV-2 2021 ·Diagnostic Microbiology and Infectious Disease ·Byron M. Berenger, Kevin Fonseca, Angela Schneider, Jia Hu, Nathan Zelyas	10
13	Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic 2021 ·Virology Journal ·Natalie C. Marshall, Ruwandi Kariyawasam, Nathan Zelyas, Jamil N. Kanji, Mathew Diggle	18
14	A Public Health Laboratory Response to the Pandemic 2020 ·Journal of Clinical Microbiology ·Kanti Pabbaraju, Anita Wong, (unknown), (unknown), Kara Gill, (unknown), Kevin Fonseca, Nathan Zelyas, Graham Tipples	22
15	Association between Mycoplasma and Ureaplasma airway positivity, ammonia levels, and outcomes post–lung transplantation: A prospective surveillance study 2020 ·American Journal of Transplantation ·(unknown), Jutta K. Preiksaitis, K. Halloran, Jayan Nagendran, Derek R. Townsend, Nathan Zelyas, Wendy Sligl	18
16	First hospitalized case of laboratory-confirmed coronavirus infectious disease 2019 (COVID-19) in Alberta, Canada 2020 ·Journal of the Association of Medical Microbiology and Infectious Disease Canada ·Jamil N. Kanji, (unknown), (unknown), Nelson Lee, Graham Tipples, Nathan Zelyas	2
17	Comparative Evaluation of Enteric Bacterial Culture and a Molecular Multiplex Syndromic Panel in Children with Acute Gastroenteritis 2019 ·Journal of Clinical Microbiology ·(unknown), Brendon Parsons, Linda Chui, Byron M. Berenger, Jianling Xie, Carey‐Ann D. Burnham, Phillip I. Tarr, Bonita E. Lee, Alberto Nettel‐Aguirre, (unknown), Otto G. Vanderkooi, Xiaoli Pang, Nathan Zelyas, Stephen B. Freedman	31
18	Detection, Characterization, and Typing of Shiga Toxin-Producing Escherichia coli 2016 ·Frontiers in Microbiology ·Brendon Parsons, Nathan Zelyas, Byron M. Berenger, Linda Chui	64
19	Assessment of commercial chromogenic solid media for the detection of non-O157 Shiga toxin-producing Escherichia coli (STEC) 2016 ·Diagnostic Microbiology and Infectious Disease ·Nathan Zelyas, (unknown), Laura Patterson-Fortin, Roger P. Johnson, (unknown), Linda Chui	23
20	Use of the native flp gene to generate in-frame unmarked mutations in Streptomyces spp. 2009 ·Gene ·Nathan Zelyas, Kapil Tahlan, Susan E. Jensen	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact